TuHURA BIOSCIENCES, INC./NV Deferred Costs, Current
TuHURA BIOSCIENCES, INC./NV (HURA) had Deferred Costs, Current of $94.00 thousand as of 2020-06-30, per its 10-K filed 2021-09-28.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredCostsCurrent · last filed 2021-09-28
- 2020-06-30: Deferred Costs, Current $94.00K; Deferred Costs, Current as first filed $93.70K.
- 2017-03-31: Deferred Costs, Current $25.70K.
- 2016-03-31: Deferred Costs, Current $60.65K.
- 2015-06-30: Deferred Costs, Current $550.12K.
| Period end | Deferred Costs, Current | Deferred Costs, Current as first filed |
|---|---|---|
| 2020-06-30 | $94.00K 10-K · filed 2021-09-28 | $93.70K 10-K · filed 2020-09-18 |
| 2017-03-31 | $25.70K 10-Q · filed 2017-05-12 | |
| 2016-03-31 | $60.65K 10-Q · filed 2016-05-12 | |
| 2015-06-30 | $550.12K 10-K · filed 2017-09-27 | |
| 2012-12-31 | $90.77K 10-K · filed 2014-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |